Crosstalk between SIRT1/Nrf2 signaling and NLRP3 inflammasome/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson's disease.

Autor: Ghaith WZ; Egyptian Town Gas Company, Medical Department, Cairo, Egypt., Wadie W; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, 11562, Egypt., El-Yamany MF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, 11562, Egypt. Electronic address: walaa.wadie@pharma.cu.edu.eg.

Publikováno v: International immunopharmacology [Int Immunopharmacol] 2024 Dec 04; Vol. 145, pp. 113716. Date of Electronic Publication: 2024 Dec 04.